Click for best price
Cell Therapy Tissue Engineering Market Size, Share 2023
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy and Tissue Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy and Tissue Engineering. This report contains market size and forecasts of Cell Therapy and Tissue Engineering in global, including the following market information:
Global Cell Therapy and Tissue Engineering Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cell Therapy and Tissue Engineering market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
We surveyed the Cell Therapy and Tissue Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy and Tissue Engineering Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Type, 2022 (%)
Cell Therapy
Tissue Engineering
Global Cell Therapy and Tissue Engineering Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Application, 2022 (%)
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
Global Cell Therapy and Tissue Engineering Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy and Tissue Engineering revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell Therapy and Tissue Engineering revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell Therapy and Tissue Engineering, market overview.
Chapter 2: Global Cell Therapy and Tissue Engineering market size in revenue.
Chapter 3: Detailed analysis of Cell Therapy and Tissue Engineering company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell Therapy and Tissue Engineering in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cell Therapy and Tissue Engineering Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell Therapy and Tissue Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy and Tissue Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy and Tissue Engineering Overall Market Size
2.1 Global Cell Therapy and Tissue Engineering Market Size: 2022 VS 2030
2.2 Global Cell Therapy and Tissue Engineering Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Therapy and Tissue Engineering Players in Global Market
3.2 Top Global Cell Therapy and Tissue Engineering Companies Ranked by Revenue
3.3 Global Cell Therapy and Tissue Engineering Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy and Tissue Engineering Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell Therapy and Tissue Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy and Tissue Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell Therapy and Tissue Engineering Market Size Markets, 2022 & 2030
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.2 By Type - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
4.2.2 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
4.2.3 By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy and Tissue Engineering Market Size, 2022 & 2030
5.1.2 Cell Defects
5.1.3 Genetic Diseases
5.1.4 Neurodegenerative Diseases
5.1.5 Tissue Malignancies
5.1.6 Others
5.2 By Application - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
5.2.2 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
5.2.3 By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell Therapy and Tissue Engineering Market Size, 2022 & 2030
6.2 By Region - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
6.2.2 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
6.2.3 By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.3.2 US Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.3.3 Canada Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.3.4 Mexico Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.4.2 Germany Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.3 France Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.4 U.K. Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.5 Italy Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.6 Russia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.7 Nordic Countries Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.8 Benelux Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.5.2 China Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.3 Japan Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.4 South Korea Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.5 Southeast Asia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.6 India Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.6.2 Brazil Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.6.3 Argentina Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.7.2 Turkey Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.3 Israel Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.4 Saudi Arabia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.5 UAE Cell Therapy and Tissue Engineering Market Size, 2018-2030
7 Cell Therapy and Tissue Engineering Companies Profiles
7.1 Betalin Therapeutics
7.1.1 Betalin Therapeutics Company Summary
7.1.2 Betalin Therapeutics Business Overview
7.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Major Product Offerings
7.1.4 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.1.5 Betalin Therapeutics Key News & Latest Developments
7.2 BioCardia, Inc
7.2.1 BioCardia, Inc Company Summary
7.2.2 BioCardia, Inc Business Overview
7.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.2.4 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.2.5 BioCardia, Inc Key News & Latest Developments
7.3 BioReliance Corporation
7.3.1 BioReliance Corporation Company Summary
7.3.2 BioReliance Corporation Business Overview
7.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Major Product Offerings
7.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.3.5 BioReliance Corporation Key News & Latest Developments
7.4 Biosolution Co.
7.4.1 Biosolution Co. Company Summary
7.4.2 Biosolution Co. Business Overview
7.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Major Product Offerings
7.4.4 Biosolution Co. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.4.5 Biosolution Co. Key News & Latest Developments
7.5 Brainstorm Cell Therapeutics, Inc
7.5.1 Brainstorm Cell Therapeutics, Inc Company Summary
7.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
7.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.5.4 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.5.5 Brainstorm Cell Therapeutics, Inc Key News & Latest Developments
7.6 MaxCyte, Inc
7.6.1 MaxCyte, Inc Company Summary
7.6.2 MaxCyte, Inc Business Overview
7.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.6.4 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.6.5 MaxCyte, Inc Key News & Latest Developments
7.7 Medigene AG
7.7.1 Medigene AG Company Summary
7.7.2 Medigene AG Business Overview
7.7.3 Medigene AG Cell Therapy and Tissue Engineering Major Product Offerings
7.7.4 Medigene AG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.7.5 Medigene AG Key News & Latest Developments
7.8 MEDIPOST CO.
7.8.1 MEDIPOST CO. Company Summary
7.8.2 MEDIPOST CO. Business Overview
7.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Major Product Offerings
7.8.4 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.8.5 MEDIPOST CO. Key News & Latest Developments
7.9 Mesoblast Limited
7.9.1 Mesoblast Limited Company Summary
7.9.2 Mesoblast Limited Business Overview
7.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Major Product Offerings
7.9.4 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.9.5 Mesoblast Limited Key News & Latest Developments
7.10 Miromatrix Medical, Inc.
7.10.1 Miromatrix Medical, Inc. Company Summary
7.10.2 Miromatrix Medical, Inc. Business Overview
7.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.10.4 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.10.5 Miromatrix Medical, Inc. Key News & Latest Developments
7.11 MolMed S.p.A
7.11.1 MolMed S.p.A Company Summary
7.11.2 MolMed S.p.A Business Overview
7.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Major Product Offerings
7.11.4 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.11.5 MolMed S.p.A Key News & Latest Developments
7.12 Mustang Bio, Inc
7.12.1 Mustang Bio, Inc Company Summary
7.12.2 Mustang Bio, Inc Business Overview
7.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.12.4 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.12.5 Mustang Bio, Inc Key News & Latest Developments
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Company Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.13.4 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.13.5 NantKwest, Inc. Key News & Latest Developments
7.14 Neuralstem, Inc
7.14.1 Neuralstem, Inc Company Summary
7.14.2 Neuralstem, Inc Business Overview
7.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.14.4 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.14.5 Neuralstem, Inc Key News & Latest Developments
7.15 NexImmune, Inc.
7.15.1 NexImmune, Inc. Company Summary
7.15.2 NexImmune, Inc. Business Overview
7.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.15.4 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.15.5 NexImmune, Inc. Key News & Latest Developments
7.16 Nohla Therapeutics, Inc
7.16.1 Nohla Therapeutics, Inc Company Summary
7.16.2 Nohla Therapeutics, Inc Business Overview
7.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.16.4 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.16.5 Nohla Therapeutics, Inc Key News & Latest Developments
7.17 ReNeuron Group plc
7.17.1 ReNeuron Group plc Company Summary
7.17.2 ReNeuron Group plc Business Overview
7.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.17.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.17.5 ReNeuron Group plc Key News & Latest Developments
7.18 Richter-Helm BioLogics GmbH & Co. KG
7.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Summary
7.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.18.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.18.5 Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
7.19 RoosterBio, Inc
7.19.1 RoosterBio, Inc Company Summary
7.19.2 RoosterBio, Inc Business Overview
7.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.19.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.19.5 RoosterBio, Inc Key News & Latest Developments
7.20 RoslinCT
7.20.1 RoslinCT Company Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.20.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.20.5 RoslinCT Key News & Latest Developments
7.21 Rubius Therapeutics, Inc.
7.21.1 Rubius Therapeutics, Inc. Company Summary
7.21.2 Rubius Therapeutics, Inc. Business Overview
7.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.21.4 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.21.5 Rubius Therapeutics, Inc. Key News & Latest Developments
7.22 Sangamo Therapeutics, Inc
7.22.1 Sangamo Therapeutics, Inc Company Summary
7.22.2 Sangamo Therapeutics, Inc Business Overview
7.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.22.4 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.22.5 Sangamo Therapeutics, Inc Key News & Latest Developments
7.23 Voyager Therapeutics, Inc
7.23.1 Voyager Therapeutics, Inc Company Summary
7.23.2 Voyager Therapeutics, Inc Business Overview
7.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.23.4 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.23.5 Voyager Therapeutics, Inc Key News & Latest Developments
7.24 Waisman Biomanufacturing
7.24.1 Waisman Biomanufacturing Company Summary
7.24.2 Waisman Biomanufacturing Business Overview
7.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Major Product Offerings
7.24.4 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.24.5 Waisman Biomanufacturing Key News & Latest Developments
7.25 WindMIL Therapeutics, Inc.
7.25.1 WindMIL Therapeutics, Inc. Company Summary
7.25.2 WindMIL Therapeutics, Inc. Business Overview
7.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.25.4 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.25.5 WindMIL Therapeutics, Inc. Key News & Latest Developments
7.26 Wuxi App Tec, Inc.
7.26.1 Wuxi App Tec, Inc. Company Summary
7.26.2 Wuxi App Tec, Inc. Business Overview
7.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.26.4 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.26.5 Wuxi App Tec, Inc. Key News & Latest Developments
7.27 ReNeuron Group plc
7.27.1 ReNeuron Group plc Company Summary
7.27.2 ReNeuron Group plc Business Overview
7.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.27.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.27.5 ReNeuron Group plc Key News & Latest Developments
7.28 Richter-Helm BioLogics GmbH & Co. KG
7.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Summary
7.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.28.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.28.5 Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
7.29 RoosterBio, Inc
7.29.1 RoosterBio, Inc Company Summary
7.29.2 RoosterBio, Inc Business Overview
7.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.29.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.29.5 RoosterBio, Inc Key News & Latest Developments
7.30 RoslinCT
7.30.1 RoslinCT Company Summary
7.30.2 RoslinCT Business Overview
7.30.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.30.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.30.5 RoslinCT Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell Therapy and Tissue Engineering Market Opportunities & Trends in Global Market
Table 2. Cell Therapy and Tissue Engineering Market Drivers in Global Market
Table 3. Cell Therapy and Tissue Engineering Market Restraints in Global Market
Table 4. Key Players of Cell Therapy and Tissue Engineering in Global Market
Table 5. Top Cell Therapy and Tissue Engineering Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell Therapy and Tissue Engineering Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell Therapy and Tissue Engineering Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell Therapy and Tissue Engineering Product Type
Table 9. List of Global Tier 1 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2024-2030
Table 30. Betalin Therapeutics Company Summary
Table 31. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Offerings
Table 32. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 33. Betalin Therapeutics Key News & Latest Developments
Table 34. BioCardia, Inc Company Summary
Table 35. BioCardia, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 36. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 37. BioCardia, Inc Key News & Latest Developments
Table 38. BioReliance Corporation Company Summary
Table 39. BioReliance Corporation Cell Therapy and Tissue Engineering Product Offerings
Table 40. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 41. BioReliance Corporation Key News & Latest Developments
Table 42. Biosolution Co. Company Summary
Table 43. Biosolution Co. Cell Therapy and Tissue Engineering Product Offerings
Table 44. Biosolution Co. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 45. Biosolution Co. Key News & Latest Developments
Table 46. Brainstorm Cell Therapeutics, Inc Company Summary
Table 47. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 48. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 49. Brainstorm Cell Therapeutics, Inc Key News & Latest Developments
Table 50. MaxCyte, Inc Company Summary
Table 51. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 52. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 53. MaxCyte, Inc Key News & Latest Developments
Table 54. Medigene AG Company Summary
Table 55. Medigene AG Cell Therapy and Tissue Engineering Product Offerings
Table 56. Medigene AG Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 57. Medigene AG Key News & Latest Developments
Table 58. MEDIPOST CO. Company Summary
Table 59. MEDIPOST CO. Cell Therapy and Tissue Engineering Product Offerings
Table 60. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 61. MEDIPOST CO. Key News & Latest Developments
Table 62. Mesoblast Limited Company Summary
Table 63. Mesoblast Limited Cell Therapy and Tissue Engineering Product Offerings
Table 64. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 65. Mesoblast Limited Key News & Latest Developments
Table 66. Miromatrix Medical, Inc. Company Summary
Table 67. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 68. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 69. Miromatrix Medical, Inc. Key News & Latest Developments
Table 70. MolMed S.p.A Company Summary
Table 71. MolMed S.p.A Cell Therapy and Tissue Engineering Product Offerings
Table 72. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 73. MolMed S.p.A Key News & Latest Developments
Table 74. Mustang Bio, Inc Company Summary
Table 75. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 76. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 77. Mustang Bio, Inc Key News & Latest Developments
Table 78. NantKwest, Inc. Company Summary
Table 79. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 80. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 81. NantKwest, Inc. Key News & Latest Developments
Table 82. Neuralstem, Inc Company Summary
Table 83. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 84. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 85. Neuralstem, Inc Key News & Latest Developments
Table 86. NexImmune, Inc. Company Summary
Table 87. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 88. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 89. NexImmune, Inc. Key News & Latest Developments
Table 90. Nohla Therapeutics, Inc Company Summary
Table 91. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 92. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 93. Nohla Therapeutics, Inc Key News & Latest Developments
Table 94. ReNeuron Group plc Company Summary
Table 95. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 96. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 97. ReNeuron Group plc Key News & Latest Developments
Table 98. Richter-Helm BioLogics GmbH & Co. KG Company Summary
Table 99. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 100. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 101. Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
Table 102. RoosterBio, Inc Company Summary
Table 103. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 104. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 105. RoosterBio, Inc Key News & Latest Developments
Table 106. RoslinCT Company Summary
Table 107. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 108. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 109. RoslinCT Key News & Latest Developments
Table 110. Rubius Therapeutics, Inc. Company Summary
Table 111. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 112. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 113. Rubius Therapeutics, Inc. Key News & Latest Developments
Table 114. Sangamo Therapeutics, Inc Company Summary
Table 115. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 116. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 117. Sangamo Therapeutics, Inc Key News & Latest Developments
Table 118. Voyager Therapeutics, Inc Company Summary
Table 119. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 120. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 121. Voyager Therapeutics, Inc Key News & Latest Developments
Table 122. Waisman Biomanufacturing Company Summary
Table 123. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Offerings
Table 124. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 125. Waisman Biomanufacturing Key News & Latest Developments
Table 126. WindMIL Therapeutics, Inc. Company Summary
Table 127. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 128. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 129. WindMIL Therapeutics, Inc. Key News & Latest Developments
Table 130. Wuxi App Tec, Inc. Company Summary
Table 131. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 132. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 133. Wuxi App Tec, Inc. Key News & Latest Developments
Table 134. ReNeuron Group plc Company Summary
Table 135. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 136. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 137. ReNeuron Group plc Key News & Latest Developments
Table 138. Richter-Helm BioLogics GmbH & Co. KG Company Summary
Table 139. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 140. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 141. Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
Table 142. RoosterBio, Inc Company Summary
Table 143. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 144. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 145. RoosterBio, Inc Key News & Latest Developments
Table 146. RoslinCT Company Summary
Table 147. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 148. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn) & (2018-2023)
Table 149. RoslinCT Key News & Latest Developments
List of Figures
Figure 1. Cell Therapy and Tissue Engineering Segment by Type in 2022
Figure 2. Cell Therapy and Tissue Engineering Segment by Application in 2022
Figure 3. Global Cell Therapy and Tissue Engineering Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell Therapy and Tissue Engineering Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cell Therapy and Tissue Engineering Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2022
Figure 8. By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 16. US Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 20. Germany Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 21. France Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 28. China Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 32. India Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 34. Brazil Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
Figure 37. Turkey Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2018-2030
Figure 41. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biosolution Co. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Medigene AG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
